BerGenBio - Share Issue/Capital Change 2023

BerGenBio ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates

Bergen 30 May 2023: Reference is made to the stock exchange announcement

published by BerGenBio ASA (the "Company") earlier today, 30 May 2023, regarding

the commencement of the subscription period in the rights issue (the "Rights

Issue"). As part of this process, subscription rights have been allocated to

primary insiders and their close associates.

Martin Olin, CEO of BerGenBio ASA, has on 30 May 2023 acquired 1 046 125

subscription rights in BerGenBio ASA with no price payable.

Anders Tullgren, Chairman of the Board of Directors of BerGenBio ASA, has on 30

May 2023 acquired 1 409 872 subscription rights in BerGenBio ASA with no price

payable.

Sveinung Hole, Member of the Board of Directors of BerGenBio ASA, has on 30 May

2023 acquired 83 182 subscription rights in BerGenBio ASA with no price payable.

Svev AS, a company closely associated to Sveinung Hole, Member of the Board of

Directors of BerGenBio ASA, has on 30 May 2023 acquired 2 945 053 subscription

rights in BerGenBio ASA with no price payable.

Sarsia Seed AS, a company closely associated to Sveinung Hole, Member of the

Board of Directors of BerGenBio ASA, has on 30 May 2023 acquired 59 719 358

subscription rights in BerGenBio ASA with no price payable.

Sarsia Development AS, a company closely associated to Sveinung Hole, Member of

the Board of Directors of BerGenBio ASA, has on 30 May 2023 acquired 33 131 992

subscription rights in BerGenBio ASA with no price payable.

Please see the attached notifications of trade for information regarding the

primary insiders' and their close associates' receipt of subscription rights in

the Rights Issue.

This information is subject to the disclosure requirements pursuant to article

19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian

Securities Trading Act.

AI assistant